Search Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapySolid TumorsProtocol groupGastroenterologic OncologyradiotherapyDiseaseEsophageal CancerGastric CancerSubgroupAdenocarcinoma of the esophagogastric junction (AEG)ICD10C15.-C16.-C16.0MeSHEsophageal NeoplasmsStomach NeoplasmsSequenceARTIST, Gastric CaCAPOX (CAPE1000/OXAL130), AEG/Gastric Ca, adj., A (PID689) -|- B (PID684) -|- C (PID689)FU425/CFOL/20/Radiation, AEG/Gastric Ca, adj., A (PID697) -|- B (PID698) -|- C (PID697).ChemotherapyChemo-substanceCapecitabineFluorouracilFolinic acidOxaliplatinChemo-substanceCapecitabineFluorouracilFolinic acidOxaliplatinChemo-substanceCapecitabineFluorouracilFolinic acidOxaliplatinChemo-substanceCapecitabineFluorouracilFolinic acidOxaliplatinNo. Substances12 RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionDexamethasoneGranisetronSupportive substanceBalanced Crystalloid SolutionDexamethasoneGranisetronSupportive substanceBalanced Crystalloid SolutionDexamethasoneGranisetronSupportive substanceBalanced Crystalloid SolutionDexamethasoneGranisetronNo. Substances123Protocol classificationTherapy classificationalternativeIntensityStandard doseTherapy indicationTherapy phaseTherapy intentioncurativeRisksAnemia Hb below 8g/dlAnorexiaCardiotoxicityConstipationDiarrheaEmetogenicity (ASCO)Emetogenicity (MASCC/ESMO)Hand-Foot SyndromeInfectionsLeukopeniaNeuropathyNeutropeniaOral MucositisThrombocytopenia below 50 000/µl only studiesPublicationAuthorHofheinz RDLee JMacDonald JSDiseaseAdenokarzinom des Magens nach R0 Resektion und D2 Lymphknoten Dissektion, ECOG 0-1Adenokarzinom des Magens oder gastroösophagealen Übergangs nach R0 Resektion, Stadium Ib-IV, ECOG 0-1Patienten mit operiertem Karzinom des gastroösophagealen Übergangs oder des MagensOriginausgedehnte MARGIT / AIO StudieSt. Vincent´s Comprehensive Cancer Center, New YorkSungkyunkwan University School of Medicine, Seoul, Korea, The ARTIST trialProtocols in Revision 5 protocols foundProtocols under revision.Capecitabine 825 / Radiation, Gastric Cancer, adjuvant (PID2243 V1.0)CAPOX - Capecitabine 1000 / Oxaliplatin 130, Adenocarcinoma Esophagogastric Junction and Stomach, adjuvant, part A+C (PID689 V1.3)CAPOX / Radiation - Capecitabine 825 / Oxaliplatin 40 / Radiation, adenocarcinoma esophagogastric junction and stomach, adjuvant, Part B (PID684 V1.4)Fluorouracil 400 / Folinic Acid 20 / Radiation, Adenocarcinoma Esophagogastric Junction and Stomach, adjuvant, Part B (PID698 V1.2)Fluorouracil 425 / Folinic Acid 20, Adenocarcinoma Esophagogastric Junction and Stomach, adjuvant, part A+C. (PID697 V1.2)
